These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11723766)

  • 1. Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon.
    Russell KA; Specks U
    Rheum Dis Clin North Am; 2001 Nov; 27(4):815-32, vii. PubMed ID: 11723766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Kettritz R
    J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte-endothelial interactions in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Harper L; Savage CO
    Rheum Dis Clin North Am; 2001 Nov; 27(4):887-903. PubMed ID: 11723770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-neutrophil cytoplasmic antibodies on proteinase 3-induced apoptosis of human endothelial cells.
    Taekema-Roelvink ME; van Kooten C; Janssens MC; Heemskerk E; Daha MR
    Scand J Immunol; 1998 Jul; 48(1):37-43. PubMed ID: 9714408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies.
    O'Brien EC; Abdulahad WH; Rutgers A; Huitema MG; O'Reilly VP; Coughlan AM; Harrington M; Heeringa P; Little MA; Hickey FB
    Sci Rep; 2015 Jul; 5():11888. PubMed ID: 26149790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What you should know about PR3-ANCA. An introduction.
    Wiik A
    Arthritis Res; 2000; 2(4):252-4. PubMed ID: 11094436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
    Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
    Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil functions of patients with vasculitis related to myeloperoxidase-specific anti-neutrophil antibody.
    Suzuki K
    Int J Hematol; 2001 Aug; 74(2):134-43. PubMed ID: 11594512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.
    Pankhurst T; Savage CO
    Curr Opin Pharmacol; 2006 Apr; 6(2):190-6. PubMed ID: 16483847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
    Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
    J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the pathogenesis of ANCA-associated vasculitis.
    Day CJ; Hewins P; Savage CO
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S35-48. PubMed ID: 14740426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to neutrophil granule proteins: pathogenic potential in vasculitis?
    Locke IC; Cambridge G
    Br J Biomed Sci; 1996 Dec; 53(4):302-16. PubMed ID: 9069109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody.
    Land J; Rutgers A; Kallenberg CG
    Nephrol Dial Transplant; 2014 Apr; 29(4):739-45. PubMed ID: 24398891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.